Comparative In Vitro Activities of Caspofungin and Micafungin, Determined Using the Method of the European Committee on Antimicrobial Susceptibility Testing, against Yeast Isolates Obtained in France in 2005-2006 - Dannaoui, E.; Lortholary, O.; Raoux, D.; Bougnoux, M. E.; Galeazzi, G.; Lawrence, C.; Moissenet, D.; Poilane, I.; Hoinard, D.; Dromer, F. (Antimicrobial Agents and Chemotherapy, 2008)
Keywords: Antibiotics. Antiinfectious agents. Antiparasitic agents; Antifungal Agents; Antifungal Agents - pharmacology; Biological and medical sciences; Candida - classification; Candida - drug effects; Candida albicans; Candida glabrata; Candida guilliermondii; Candida krusei; Candida parapsilosis; Candida tropicalis; Drug Resistance, Fungal; Echinocandins; Echinocandins - pharmacology; France; Humans; Life Sciences; Lipopeptides; Lipoproteins; Lipoproteins - pharmacology; Medical sciences; Microbial Sensitivity Tests - standards; Mycoses - microbiology; Pharmacology. Drug treatments; Susceptibility; Yeasts; Yeasts - classification; Yeasts - drug effects; France; Europe; Yeast; Drug susceptibility test; Enzyme; Transferases; Glycosyltransferases; Enzyme inhibitor; 1,3-β-Glucan synthase; Method; Micafungin; In vitro; Echinocandine derivatives; Biological activity; Antifungal agent; Sensitivity resistance; Caspofungin; Isolate; Hexosyltransferases; Antibacterial agent; Comparative study